Notably, elevated MET expression drives metastatic progression in thyroid cancer, a finding corroborated by clinical specimen analysis revealing a significant correlation between high MET expression and metastatic potential (P = 0.0002). The gene discussed is MET; the disease is thyroid gland carcinoma.